2025年醫療保健領域生成式人工智慧全球市場報告

預計未來幾年，醫療保健領域的生成式人工智慧市場將呈指數級成長，到2029年將達到104.6億美元，複合年成長率為34.1%。預測期內的成長可歸因於醫學影像技術的進步、人工智慧監測系統的興起、全球化進程的加速、病患群體的不斷成長、新型醫療治療方法以及虛擬病患模擬的興起。預測期內的主要趨勢包括增強型醫學影像、遠端醫療和遠端監測、穩健性和泛化能力、生成式人工智慧演算法的進步、先進的心臟數據分析、醫療保健數據分析以及即時健康監測。

預測的五年成長率為34.1%，較我們先前對該市場的預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能會阻礙美國數位醫療的普及，因為它會推高加拿大和美國開發的人工智慧(AI)診斷演算法和雲端處理基礎設施的價格，從而延緩臨床應用並增加醫療IT支出。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

醫療保健領域生成式人工智慧市場的成長預計將受到個人化醫療需求不斷成長的推動。個人化醫療，也稱為精準醫療，透過考慮每個患者的基因、環境和生活方式的個別差異來徹底改變治療方法。個人化醫療需求的激增受到多種因素的推動，包括基因組學的進步、對疾病機制的更深入了解以及對更有效、更有針對性的治療的追求。醫療保健領域的生成式人工智慧採用演算法分析大量病患資料（包括基因圖譜和病歷），以建立針對每個病患特徵和需求的個人化治療方案和預測。例如，根據個人化醫療聯盟 2024 年 2 月的數據，FDA 的 CDER 在 2023 年核准了16 種針對罕見疾病患者的新個人化治療方法，比 2022 年的 6 種顯著增加。其中，七種用於治療癌症，另外三種用於治療其他各種疾病和病症。因此，個人化醫療日益成長的需求正在推動醫療保健領域生成性人工智慧市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球醫療保健領域的生成人工智慧：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球醫療保健市場中的生成人工智慧：成長率分析
• 全球醫療保健生成人工智慧市場表現：規模與成長，2019-2024
• 全球醫療保健生成人工智慧市場預測：規模與成長，2024-2029 年，2034 年預測
• 醫療保健領域的生成式人工智慧：全球潛在市場總量 (TAM)

第6章 市場細分

• 全球醫療保健領域產生人工智慧市場：按組成部分、實際規模和預測，2019-2024 年、2024-2029 年、2034 年
• 解決方案
• 服務
• 全球醫療保健領域生成人工智慧市場：按功能、實際情況和預測，2019-2024 年、2024-2029 年、2034 年
• 人工智慧輔助機器人手術
• 虛擬護理助理
• 輔助臨床決策與診斷
• 工作流程與管理任務
• 影像分析
• 全球醫療保健領域生成式人工智慧市場：按應用、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 臨床
• 系統
• 全球醫療保健領域生成式人工智慧市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 臨床研究
• 醫療機構
• 診斷中心
• 其他最終用戶
• 全球醫療保健領域生成式人工智慧市場：按解決方案類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 診斷影像分析
• 藥物發現與開發工具
• 個人化治療方案
• 人工智慧臨床決策支持
• 全球醫療保健市場中的生成人工智慧：按服務類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
• 諮詢和顧問服務
• 實施和整合服務
• 支援和維護服務
• 培訓和教育服務

第7章 區域和國家分析

• 全球醫療保健領域生成式人工智慧市場：區域表現與預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球醫療保健領域生成式人工智慧市場：國家、表現與預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 醫療保健領域的生成式人工智慧：競爭格局
• 醫療保健市場中的生成人工智慧：公司簡介
  • Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Intel Corporation
• IBM Watson Health Corporation
• Ernst & Young Global Limited
• Oracle Corporation
• Nvidia Corporation
• Harman International Industries Inc.
• Epic Systems Corporation
• Persistent Systems Private Limited
• Tempus Labs Inc.
• Eleks Inc.
• NioyaTech LLC
• Saxon Global Inc.
• Verge Genomics Inc.
• PathAI Inc.
• BenevolentAI Ltd

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年醫療保健市場中的生成式人工智慧：提供新機會的國家
• 2029 年醫療保健市場中的生成式人工智慧：提供新機會的細分領域
• 2029 年醫療保健市場中的生成式人工智慧：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Generative AI in healthcare encompasses the utilization of advanced artificial intelligence models specifically tailored to address the distinctive requirements and complexities of medical practice. These models have the capability to generate detailed simulations based on real-world data, enabling researchers and medical professionals to test hypotheses within a safe environment. This technology is leveraged to generate novel insights and data aimed at enhancing patient outcomes, expediting medical research, and improving the delivery of healthcare services.

The primary components of generative AI in healthcare consist of solutions and services. Services refer to intangible, non-physical components of the economy, in contrast to tangible goods that can be physically touched or handled. These encompass various functions including AI-assisted robotic surgery, virtual nursing assistants, support for clinical judgment or diagnosis, assistance with workflow and administrative tasks, and image analysis, all serving diverse applications such as clinical and systems. Generative AI in healthcare caters to a broad spectrum of end-users including hospitals and clinics, clinical research institutions, healthcare organizations, diagnostic centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The generative AI in healthcare market research report is one of a series of new reports from The Business Research Company that provides generative AI in healthcare market statistics, including the generative AI in healthcare industry global market size, regional shares, competitors with generative AI in healthcare market share, detailed generative AI in healthcare market segments, market trends, and opportunities, and any further data you may need to thrive in the generative AI in healthcare industry. This generative AI in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generative ai in healthcare market size has grown exponentially in recent years. It will grow from $2.36 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 36.8%. The growth in the historic period can be attributed to increased healthcare data analytics, increased demand for personalized medicine, increased demand for AI-enabled healthcare solutions, increased demand for personalized treatment plans, and increased drug discovery and development processes.

The generative ai in healthcare market size is expected to see exponential growth in the next few years. It will grow to $10.46 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to increasing medical imaging techniques, increasing AI-powered monitoring systems, increasing globalization, increasing patients, increasing modern medical treatments, and increasing virtual patient simulation. Major trends in the forecast period include medical imaging enhancement, telemedicine and remote monitoring, robustness and generalization, advances in generative AI algorithms, advanced cardiac data analysis, healthcare data analytics, and real-time health monitoring.

The forecast of 34.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. digital health adoption by inflating prices of Artificial intelligence(AI)-powered diagnostic algorithms and cloud computing infrastructure developed in Canada and Finland, resulting in delayed clinical implementation and higher health IT expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the generative AI in healthcare market is expected to be driven by the increasing demand for personalized medicine in the future. Personalized medicine, also referred to as precision medicine, revolutionizes medical treatment by considering individual differences in genes, environment, and lifestyle for each patient. This demand surge for personalized medicine is propelled by various factors, including advancements in genomics, a deeper understanding of disease mechanisms, and the quest for more efficient and targeted therapies. Generative AI in healthcare employs algorithms to analyze extensive patient data, encompassing genetic profiles and medical histories, to craft personalized treatment options and predictions tailored to individual patient characteristics and needs. For instance, according to the Personalized Medicine Coalition in February 2024, the FDA's CDER approved 16 new personalized treatments for rare disease patients in 2023, marking a notable increase from 6 approvals in 2022. Among these treatments, seven were tailored for cancer therapy, with an additional three designed for addressing various other diseases and conditions. Hence, the rising demand for personalized medicine is propelling the growth of the generative AI in healthcare market.

Key players in the generative AI in healthcare market are concentrating on establishing strategic partnerships to drive innovation and gain a competitive advantage. These partnerships play a pivotal role in advancing generative AI in healthcare by harnessing the strengths and resources of multiple organizations to develop groundbreaking solutions, enhance clinical workflows' efficiency, and tackle critical healthcare challenges. For example, in June 2023, Google partnered with Mayo Clinic to integrate generative AI into healthcare. This collaboration aims to leverage generative AI's potential to streamline operations, enhance healthcare delivery, and enable real-time personalized interactions by unlocking previously inaccessible information. Initially focusing on Enterprise Search in Gen App Builder, the partnership aims to improve clinical workflows and patient outcomes while ensuring compliance with HIPAA regulations.

In March 2022, Microsoft Corporation acquired Nuance Communications for approximately $19.7 billion. Through this acquisition, Microsoft aims to bolster its presence in the enterprise software market, particularly in healthcare, and advance its cloud computing business. Nuance Communications specializes in providing generative AI in healthcare and is known for its expertise in the field.

Major companies operating in the generative AI in healthcare market report are Alphabet Inc.; Microsoft Corporation; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; Siemens AG; Intel Corporation; IBM Watson Health Corporation; Ernst & Young Global Limited; Oracle Corporation; Nvidia Corporation; Harman International Industries Inc.; Epic Systems Corporation; Persistent Systems Private Limited; Tempus Labs Inc.; Eleks Inc.; NioyaTech LLC; Saxon Global Inc.; Verge Genomics Inc.; PathAI Inc.; BenevolentAI Ltd; Abridge AI Inc.; Absci Corporation; Atomwise Inc.; Syntegra; Insilico Medicine; Neuralink Corporation; DiagnaMed Holdings Corp.

North America was the largest region in the generative AI in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative AI in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative AI in healthcare market includes revenues earned by entities by providing services such as drug discovery process, medical imaging, medical research, personalized treatment plans, medical simulations, and detecting billing fraud. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative ai in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative ai in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative ai in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Solutions; Services
• 2) By Function: AI-Assisted Robotic Surgery; Virtual Nursing Assistants; Aid Clinical Judgment Or Diagnosis; Workflow And Administrative Tasks; Image Analysis
• 3) By Application: Clinical; System
• 4) By End User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Solutions: Diagnostic Imaging Analysis; Drug Discovery And Development Tools; Personalized Treatment Planning; AI-Powered Clinical Decision Support
• 2) By Services: Consulting and Advisory Services; Implementation And Integration Services; Support And Maintenance Services; Training And Education Services
• Companies Mentioned: Alphabet Inc.; Microsoft Corporation; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; Siemens AG; Intel Corporation; IBM Watson Health Corporation; Ernst & Young Global Limited; Oracle Corporation; Nvidia Corporation; Harman International Industries Inc.; Epic Systems Corporation; Persistent Systems Private Limited; Tempus Labs Inc.; Eleks Inc.; NioyaTech LLC; Saxon Global Inc.; Verge Genomics Inc.; PathAI Inc.; BenevolentAI Ltd; Abridge AI Inc.; Absci Corporation; Atomwise Inc.; Syntegra; Insilico Medicine; Neuralink Corporation; DiagnaMed Holdings Corp.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative AI In Healthcare Market Characteristics

3. Generative AI In Healthcare Market Trends And Strategies

4. Generative AI In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Generative AI In Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Generative AI In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Generative AI In Healthcare Market Growth Rate Analysis
• 5.4. Global Generative AI In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Generative AI In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Generative AI In Healthcare Total Addressable Market (TAM)

6. Generative AI In Healthcare Market Segmentation

• 6.1. Global Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solutions
• Services
• 6.2. Global Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Assisted Robotic Surgery
• Virtual Nursing Assistants
• Aid Clinical Judgment Or Diagnosis
• Workflow And Administrative Tasks
• Image Analysis
• 6.3. Global Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical
• System
• 6.4. Global Generative AI In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Clinical Research
• Healthcare Organizations
• Diagnostic Centers
• Other End Users
• 6.5. Global Generative AI In Healthcare Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging Analysis
• Drug Discovery And Development Tools
• Personalized Treatment Planning
• AI-Powered Clinical Decision Support
• 6.6. Global Generative AI In Healthcare Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting and Advisory Services
• Implementation And Integration Services
• Support And Maintenance Services
• Training And Education Services

7. Generative AI In Healthcare Market Regional And Country Analysis

• 7.1. Global Generative AI In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Generative AI In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative AI In Healthcare Market

• 8.1. Asia-Pacific Generative AI In Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative AI In Healthcare Market

• 9.1. China Generative AI In Healthcare Market Overview
• 9.2. China Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative AI In Healthcare Market

• 10.1. India Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative AI In Healthcare Market

• 11.1. Japan Generative AI In Healthcare Market Overview
• 11.2. Japan Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative AI In Healthcare Market

• 12.1. Australia Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative AI In Healthcare Market

• 13.1. Indonesia Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative AI In Healthcare Market

• 14.1. South Korea Generative AI In Healthcare Market Overview
• 14.2. South Korea Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative AI In Healthcare Market

• 15.1. Western Europe Generative AI In Healthcare Market Overview
• 15.2. Western Europe Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative AI In Healthcare Market

• 16.1. UK Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative AI In Healthcare Market

• 17.1. Germany Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative AI In Healthcare Market

• 18.1. France Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative AI In Healthcare Market

• 19.1. Italy Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative AI In Healthcare Market

• 20.1. Spain Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative AI In Healthcare Market

• 21.1. Eastern Europe Generative AI In Healthcare Market Overview
• 21.2. Eastern Europe Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative AI In Healthcare Market

• 22.1. Russia Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative AI In Healthcare Market

• 23.1. North America Generative AI In Healthcare Market Overview
• 23.2. North America Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative AI In Healthcare Market

• 24.1. USA Generative AI In Healthcare Market Overview
• 24.2. USA Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative AI In Healthcare Market

• 25.1. Canada Generative AI In Healthcare Market Overview
• 25.2. Canada Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative AI In Healthcare Market

• 26.1. South America Generative AI In Healthcare Market Overview
• 26.2. South America Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative AI In Healthcare Market

• 27.1. Brazil Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative AI In Healthcare Market

• 28.1. Middle East Generative AI In Healthcare Market Overview
• 28.2. Middle East Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative AI In Healthcare Market

• 29.1. Africa Generative AI In Healthcare Market Overview
• 29.2. Africa Generative AI In Healthcare Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Generative AI In Healthcare Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Generative AI In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative AI In Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Generative AI In Healthcare Market Competitive Landscape
• 30.2. Generative AI In Healthcare Market Company Profiles
  • 30.2.1. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

31. Generative AI In Healthcare Market Other Major And Innovative Companies

• 31.1. Intel Corporation
• 31.2. IBM Watson Health Corporation
• 31.3. Ernst & Young Global Limited
• 31.4. Oracle Corporation
• 31.5. Nvidia Corporation
• 31.6. Harman International Industries Inc.
• 31.7. Epic Systems Corporation
• 31.8. Persistent Systems Private Limited
• 31.9. Tempus Labs Inc.
• 31.10. Eleks Inc.
• 31.11. NioyaTech LLC
• 31.12. Saxon Global Inc.
• 31.13. Verge Genomics Inc.
• 31.14. PathAI Inc.
• 31.15. BenevolentAI Ltd

32. Global Generative AI In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative AI In Healthcare Market

34. Recent Developments In The Generative AI In Healthcare Market

35. Generative AI In Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Generative AI In Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Generative AI In Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Generative AI In Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer